Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferguson
FERG
|
+$1.04B |
| 2 |
GE Vernova
GEV
|
+$497M |
| 3 |
ExxonMobil
XOM
|
+$475M |
| 4 |
ResMed
RMD
|
+$398M |
| 5 |
International Paper
IP
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$887M |
| 2 |
Microsoft
MSFT
|
+$697M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$558M |
| 4 |
Waters Corp
WAT
|
+$422M |
| 5 |
AbbVie
ABBV
|
+$382M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.32% |
| 2 | Healthcare | 11.76% |
| 3 | Financials | 11.45% |
| 4 | Consumer Discretionary | 9.24% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
RBB Bancorp
RBB
$465M
| $1.64M | ﹤0.01% |
86,987
+6,781
| +8% | +$121K |
|
|
NLOP
2902
Net Lease Office Properties
NLOP
$173M
| $1.63M | ﹤0.01% |
66,080
+27,969
| +73% | +$662K |
|
2903
Bank of Marin Bancorp
BMRC
$462M
| $1.63M | ﹤0.01% |
100,460
-2,108
| -2% | -$32.4K |
|
2904
Xometry
XMTR
$5.54B
| $1.62M | ﹤0.01% |
140,522
+25,247
| +22% | +$397K |
|
|
HDSN
2905
Hudson Technologies
HDSN
$237M
| $1.62M | ﹤0.01% |
184,712
+15,392
| +9% | +$149K |
|
2906
First Trust Limited Duration Investment Grade Corporate ETF
FSIG
$1.52B
| $1.62M | ﹤0.01% |
86,581
-3,283
| -4% | -$61.4K |
|
2907
Replimune Group
REPL
$1.43B
| $1.62M | ﹤0.01% |
180,226
+17,471
| +11% | +$122K |
|
2908
Altimmune
ALT
$564M
| $1.62M | ﹤0.01% |
243,808
+54,154
| +29% | +$400K |
|
2909
UroGen Pharma
URGN
$2.33B
| $1.62M | ﹤0.01% |
96,619
+28,400
| +42% | +$404K |
|
2910
Medifast
MED
$130M
| $1.62M | ﹤0.01% |
74,251
-37,837
| -34% | -$1.01M |
|
2911
Stoneridge
SRI
$202M
| $1.62M | ﹤0.01% |
101,238
+13,236
| +15% | +$212K |
|
2912
LifeMD
LFMD
$166M
| $1.61M | ﹤0.01% |
234,583
+91,183
| +64% | +$834K |
|
2913
Teekay
TK
$1.08B
| $1.6M | ﹤0.01% |
178,904
+11,476
| +7% | +$96.7K |
|
2914
Vanguard FTSE Pacific ETF
VPL
$8.64B
| $1.6M | ﹤0.01% |
21,598
+4,755
| +28% | +$352K |
|
2915
Unisys
UIS
$209M
| $1.6M | ﹤0.01% |
386,918
+17,705
| +5% | +$86.7K |
|
|
KALV
2916
DELISTED
KalVista Pharmaceuticals
KALV
| $1.6M | ﹤0.01% |
135,600
+23,547
| +21% | +$275K |
|
2917
Mission Produce
AVO
$1.15B
| $1.6M | ﹤0.01% |
161,591
+4,160
| +3% | +$47.6K |
|
2918
FRP Holdings
FRPH
$425M
| $1.6M | ﹤0.01% |
55,945
+5,023
| +10% | +$150K |
|
2919
Mid Penn Bancorp
MPB
$975M
| $1.6M | ﹤0.01% |
72,676
+5,153
| +8% | +$107K |
|
2920
First Trust Japan AlphaDEX Fund
FJP
$267M
| $1.59M | ﹤0.01% |
30,888
+792
| +3% | +$41.8K |
|
|
DFUS
2921
Dimensional US Equity ETF
DFUS
$21.7B
| $1.59M | ﹤0.01% |
27,025
+1,387
| +5% | +$78.9K |
|
2922
First Trust Europe AlphaDEX Fund
FEP
$536M
| $1.58M | ﹤0.01% |
43,053
-443
| -1% | -$16.9K |
|
2923
ASE Group
ASX
$102B
| $1.58M | ﹤0.01% |
138,673
+838
| +0.6% | +$9.09K |
|
2924
First Bank
FRBA
$471M
| $1.58M | ﹤0.01% |
124,213
+10,590
| +9% | +$130K |
|
2925
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
$10.7B
| $1.58M | ﹤0.01% |
58,035
-34,217
| -37% | -$924K |
|
Similar funds
Bank of New York Mellon's Q2 2024 Portfolio in Review
As of Q2 2024, Bank of New York Mellon held 4,366 positions worth $528B, up 1.3% from $521B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Bank of New York Mellon's Q2 2024 filing shows 216 new, 2,305 increased, 1,454 reduced and 245 closed positions. Its largest new stake was GE Vernova: 3,134,941 shares worth $538M. The largest sale was NVIDIA, an estimated $887M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2024 buy was GE Vernova: 3,134,941 shares worth $538M.
- Bank of New York Mellon added most to Ferguson in Q2 2024, an estimated $1.04B increase.
- Bank of New York Mellon's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $887M.
- Bank of New York Mellon fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $558M.
- Bank of New York Mellon's ten largest holdings make up 25% of its $528B portfolio in Q2 2024.
- Bank of New York Mellon opened 216 new positions and closed 245 in Q2 2024.
- Bank of New York Mellon's portfolio value rose 1.3% quarter-over-quarter to $528B.
Based on Bank of New York Mellon's 13F filing for Q2 2024, filed 25 Jul 2024.